5 results match your criteria: "Warren G. Magnuson Clinical Center of the National Institutes of Health[Affiliation]"
AIDS
April 2006
National Institute of Allergy and Infectious Disease, and the Nuclear Medicine Department, Warren G. Magnuson Clinical Center of the National Institutes of Health, 10 Center Drive, MSC 1180, Bethesda, MD 20892, USA.
Objectives: Nodal uptake in areas of lymphocyte activation can be visualized using fluorodeoxyglucose. Various patterns of fluorodeoxyglucose accumulation in HIV-positive patients have been described previously and hypothesized potentially to represent regions of active HIV replication or nodal activation. We evaluated the utility of fluorodeoxyglucose scanning as a tool to study HIV pathogenesis.
View Article and Find Full Text PDFAIDS
February 2006
National Institute of Allergy and Infectious Disease, Warren G. Magnuson Clinical Center of the National Institutes of Health, Maryland 20892-1180, USA.
Objectives: Nodal uptake in areas of lymphocyte activation can be visualized using fluorodeoxyglucose (FDG). Various patterns of FDG accumulation in HIV-positive subjects have been described previously and hypothesized to potentially represent regions of active HIV replication and or nodal activation. We evaluated the utility of FDG scanning as a tool to study HIV pathogenesis.
View Article and Find Full Text PDFEthics
January 2005
Department of Clinical Bioethics, Warren G. Magnuson Clinical Center of the National Institutes of Health, USA.
MLO Med Lab Obs
February 2003
Department of Laboratory Medicine at the Warren G. Magnuson Clinical Center of the National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Transfus Med Rev
April 2001
Department of Transfusion Medicine, Warren G. Magnuson Clinical Center of the National Institutes of Health, Bethesda, MD 20894-1184, USA.